Ari Tolonen

Fabrication and characterization of Sb-doped Sn02 thin films derived from methacrylic acid modified tin(IV)alkoxides

Juha T. Rantala, Marianne Hiltunen, Ari H. O. Karkkainen, 2002, SPIE Optics + Photonics.

Lithographic patterning of benzoylacetone modified SnO2 and SnO2:Sb thin films

Terho Kololuoma, Juha T. Rantala, Ari Tolonen, 2003 .

From known knowns to known unknowns: predicting in vivo drug metabolites.

Hannu Raunio, Olavi Pelkonen, Miia Turpeinen, 2009, Bioanalysis.

Comparison of triple quadrupole, hybrid linear ion trap triple quadrupole, time-of-flight and LTQ-Orbitrap mass spectrometers in drug discovery phase metabolite screening and identification in vitro--amitriptyline and verapamil as model compounds.

Ari Tolonen, A. Tolonen, Timo Rousu, 2010, Rapid communications in mass spectrometry : RCM.

Liquid chromatography-mass spectrometry in in vitro drug metabolite screening.

Olavi Pelkonen, Miia Turpeinen, Ari Tolonen, 2009, Drug discovery today.

Comparison of metabolic stability and metabolite identification of 55 ECVAM/ICCVAM validation compounds between human and rat liver homogenates and microsomes - a preliminary analysis.

Sandra Coecke, Olavi Pelkonen, Ari Tolonen, 2009, ALTEX.

Metabolism of hyperforin, the active constituent of St. John's wort, in human liver microsomes.

Miia Turpeinen, Ari Tolonen, S. Mattila, 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.